source
- AriBio’s Alzheimer’s trial of repurposed erectile-dysfunction drug shows modest, inconclusive resultsAriBio tested a medication originally approved for erectile dysfunction as a possible therapy for Alzheimer’s disease. The recent Boston‑based study reported only modest signals and failed to show…
- AstraZeneca and Alexion receive FDA nod for Klygefa, a weekly self-administered myasthenia gravis therapyAstraZeneca and Alexion announced that the U.S. Food and Drug Administration approved their joint drug Klygefa (gefurulimab) on Monday. Klygefa is a self-administered biologic designed for patient…